About this trial
Background Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows that reintegration challenges during this transition are closely linked to increased suicide risk.
The Veteran Sponsorship Initiative (VSI) was developed to address this critical period by connecting Transitioning Servicemembers and Veterans (TSMVs) with trained, VA-certified peer sponsors. These sponsors help TSMVs navigate civilian life and access VA care. Early evaluations show that TSMVs matched with sponsors are more likely to report lower levels of reintegration difficulties, higher levels of social support, engage in VA services and report lower rates of depression and suicide risk.
This project enhances VSI by integrating predictive analytics-developed in partnership with Harvard Medical School and the DoW STARRS-LS team-to identify high-risk TSMVs before they leave the military. Those identified receive not only a sponsor but also targeted VA mental and health care services. This hybrid effectiveness-implementation study will evaluate the impact of this enhanced model (VSI+) on mental health outcomes and VA engagement among 2,700 high-risk TSMVs.
Method/Design
The purpose of this PEI proposal is to evaluate VSI expansion into VSI+ with enrollment occurring on four US Army installations (FY2026-2027). The study employs a pragmatic cluster-randomized trial with embedded mixed-method implementation evaluation to compare three arms:
1. Transition as Usual (TAU) 2. VSI Base= peer sponsorship and community support 3. VSI+= VSI Base plus VA stepped care services
The evaluation is guided by the RE-AIM framework to assess:
* Reach (enrollment rates) * Effectiveness (reintegration difficulties, depression, anxiety, suicidal ideation/behavior, and VA utilization outcomes) * Adoption (site and staff uptake) * Implementation (fidelity and feasibility) * Maintenance (sustainability)
Study Aims
1. Effectiveness: Evaluate the impact of VSI Base and VSI+ on reintegration difficulties, depression, anxiety, suicidal ideation/behavior, and VA utilization outcomes. 2. Implementation: Assess the feasibility and fidelity of implementing VSI Base and VSI+ across multiple sites using a bundled strategy. 3. Economic Impact: Estimate the budget impact of VSI Base and VSI+ on healthcare costs, including inpatient, emergency, and outpatient care.
Eligibility criteria
Qualifiers
TSMVs must be 18-years of age or older
Enroll prior to military discharge
Be planning to transition from one of the target military installations' included in the evaluation during an active enrollment window
Disqualifiers
The participants Army STARRS score cannot identify the TSMV as low risk nor as acute high risk for suicide
Trial design
Treatments tested in this trial
- Onward Ops- receive peer sponsor and community support
- VA stepped care services
Treatment groups
Sponsors and collaborators
VA Office of Research and Development
Lead sponsor
VISN 2 Mental Illness Research, Education, and Clinical Center
Collaborator
VISN 17 Center of Excellence for Research on Returning War Veterans
Collaborator
Department of War Study to Assess Risk & Resilience in Servicemembers - Longitudinal Study
Collaborator
James J. Peters Veterans Affairs Medical Center
Collaborator
Health Economics Resource Center
Collaborator